Industry
Pharmaceuticals
Developers of branded and generic drugs. Value creation rests on R&D pipelines, patent lifecycles, regulatory approvals and pricing power versus payers.
Total Companies
1 308
1 256 stocks
| Company | Last Price | Price Change | Market Cap | ||
|---|---|---|---|---|---|
|
|
|
Eli Lilly and Co
LLY
|
$1 159.165 |
+0.9%
|
$1.1T |
|
|
|
Johnson & Johnson
JNJ
|
$239.77 |
+3.3%
|
$577.2B |
|
|
|
Roche Holding AG
ROG
|
CHf324.9 |
+4.1%
|
$329.6B |
|
|
|
Merck & Co Inc
MRK
|
$119.1 |
-0.4%
|
$294.2B |
|
|
|
Novartis AG
NOVN
|
CHf119.32 |
+1.7%
|
$285.4B |
|
|
|
AstraZeneca PLC
AZN
|
GBX13 518 |
-2%
|
$279.9B |
|
|
|
Nuvo Pharmaceuticals Inc
MRV
|
CA$43.5 |
+1.2%
|
$228.1B |
|
|
|
Novo Nordisk A/S
NOVO B
|
kr281.55 |
+3.5%
|
$192.8B |
|
|
|
Pfizer Inc
PFE
|
$25.79 |
+0.7%
|
$147B |
1 251 results hidden
Create a free account to unlock additional access and upgrade to see all results
Create Free Account
